AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01070654 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: continuous positive airway pressure (CPAP)
Description: continuous positive airway pressure (CPAP)
Study NCT03480529 — intervention group
Intervention type: DRUG
Intervention: drug inducing arthritis, lupus, hepatitis, or capillary leak syndrom
Description: Drugs susceptible to induce arthritis, lupus, hepatitis, or capillary leak syndrom
Study NCT01710215 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: FIT Screening Strategy
Description: * Mailed outreach invitation to complete FIT, including a test kit (1-sample FIT, simplified instructions on how to perform the test, and return mailer with prepaid postage).~* Two live phone reminders from project staff 2 to 3 weeks after the invitation to encourage screening completion.~* Centralized processes to promote guideline-based follow up.
Study NCT01710215 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Colon Screening Strategy
Description: * Mailed outreach invitation to complete a colonoscopy, including a number to call to schedule a colonoscopy.~* Two live phone call reminders from project staff 2 to 3 weeks after the mailed invitation to encourage screening completion.~* Centralized processes to promote guideline-based follow up.
Study NCT03084042 — intervention group
Intervention type: DEVICE
Intervention: fMRI
Study NCT05425537 — intervention group
Intervention type: OTHER
Intervention: Drowning incident
Description: Drowning is defined by the WHO in 2002 as the process of experiencing respiratory impairment from submersion or immersion in liquid
Study NCT02790749 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Adjunctive hip arthroscopy to accompany PAO
Description: This is the experimental group: those patients who undergo adjunctive hip arthroscopy in addition to periacetabular osteotomy (PAO).
Study NCT02790749 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PAO without adjunctive hip arthroscopy
Description: This is the control group: those patients who undergo periacetabular osteotomy (PAO) alone, without adjunctive hip arthroscopy.
Study NCT04120025 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diaphragm Training
Description: training on isolated abdominal breathing with proper effort and hold time to promote strengthening
Study NCT00411606 — intervention group
Intervention type: PROCEDURE
Intervention: Thermography
Description: Subjects will have a picture of their face taken with a thermal camera
Study NCT00229242 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Diuretic-Based or Non-Diuretic Based Hypertension Therapy
Study NCT03098576 — intervention group
Intervention type: OTHER
Intervention: Matched targeted drug treatment
Description: Matching a specific genetic abnormality (i.e. mutation) with the appropriate targeted drug.
Study NCT03098576 — intervention group
Intervention type: OTHER
Intervention: Unmatched standard of care
Description: All patients with either no identified mutation or no available matching treatment but undergoing a systemic treatment will be enrolled in the control group.
Study NCT01985035 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Diet
Description: Reduction of energy intake in order to weight loss
Study NCT03484650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: Lidocaine bolus to be given 1 hour pre-operatively
Study NCT03484650 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lidocaine Hydrochloride
Description: Lidocaine infusion will be started after the bolus and be continued for 24 hours post-operatively
Study NCT03484650 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Control patients will receive a placebo bolus and infusion of saline to match the experimental arm.
Study NCT03461601 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: HCG Uterine flushing
Description: HCG Uterine flushing was done one day before IUI with HCG (500 IU) in 10 ml of saline.
Study NCT03461601 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: IUI
Description: Intrauterine insemination (IUI)
Study NCT03461601 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: IUI
Description: Intrauterine insemination (IUI)
Study NCT03461601 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Vaginal flushing with 10 ml normal saline
Description: Flushing of the vagina with 10 ml of saline
Study NCT03382587 — intervention group
Intervention type: DRUG
Intervention: Aflibercept (Eylea, BAY86-5321)
Description: Intravitreal aflibercept injections used in a routine treat and extend regimen, under which the intervals between the injections are extended if disease stability is maintained and no signs of worsening disease are observed on the injection day
Study NCT02945969 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low Sodium Diet
Description: Once randomized to the Intervention program, study participants will be grouped into intervention cohorts of approximately 10 participants per group to facilitate group counseling sessions. Both the intensive intervention phase and the maintenance phase will include individual and group behavioral modification counseling designed to facilitate a reduction in dietary sodium intake. Success of the intervention will be assessed by comparing the urine sodium measurements from 24-hour urine collections performed at screening, 12 weeks and 24 weeks.
Study NCT00626457 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Behavioral weight-loss/lifestyle interventions
Description: 6-month intervention (28 weekly classes)
Study NCT00626457 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Behavioral weight-loss/lifestyle interventions
Description: 6-month intervention (28 weekly classes)
Study NCT01579747 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Ultrasound
Description: Using ultrasound for nerve localization when performing a sciatic nerve block via the lateral popliteal approach
Study NCT01579747 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Nerve stimulation
Description: Using nerve stimulation for nerve localization in sciatic nerve blocks via the lateral popliteal approach
Study NCT02237092 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Measurement of IAP
Description: The level of intra-abdominal pressure was measured via a Foley catheter through the urinary bladder. After the introduction of a 30 mL of warm saline. Measurement of the water column in the system was made from the zero level to the mid-axillary line, for 10 minutes, after quiet breathing pregnant at the time of expiration.
Study NCT04679493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XC7 100 mg single
Description: The volunteers will receive a single dose of the ID (1 capsule once, 100 mg)
Study NCT04679493 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: XC7 200 mg single
Description: The volunteers will receive a single dose of the ID (2 capsules once, 100 mg each)
Study NCT03939078 — intervention group
Intervention type: RADIATION
Intervention: CO2 fractional ablative laser
Description: 3 intravaginal fractional ablative CO2 laser sessions, with one month interval between them.
Study NCT05874349 — intervention group
Intervention type: BEHAVIORAL
Intervention: General variables
Description: Variables evaluated: age, sex, location, extent, and phenotype of IBD according to the Montreal classification, smoking habit, therapeutic requirements (immunosuppressants, biologics, steroids, salicylates, drugs that cause enteropathy such as olmesartan, valsartan, non-steroidal anti-inflammatory drugs, etc, ...).
Study NCT05874349 — intervention group
Intervention type: BEHAVIORAL
Intervention: Clinical activity
Description: Clinical activity was evaluated using the Harvey-Bradshaw index (HBI) (cut-off values: \<5, remission; 5-7, mild activity; 8-16, moderate activity; and >16, severe activity).
Study NCT05874349 — intervention group
Intervention type: PROCEDURE
Intervention: Laboratory data
Description: Laboratory data: blood count, renal function and C-reactive protein, anti-transglutaminase antibodies, genetic study of celiac disease DQ2.5, DQ8, and DQ2.2, study of parasites, fecal calprotectin.
Study NCT05874349 — intervention group
Intervention type: PROCEDURE
Intervention: Endoscopic and histology data
Description: Endoscopic signs suggestive of CD in UDT (presence of canker sores, ulcers, ...) and colon inflammatory activity was evaluated when available in patients with active disease using the Simple Endoscopic Score for CD (SES-CD: 0-2, remission; 3-6, mild endoscopic activity; 7-15, moderate endoscopic activity; and >15, severe endoscopic activity).~Duodenal biopsies were assessed by 2 pathologists and were evaluated according to Marsh classification modified by Ensari \[Marsh 0, 1, 2 or 3\], the limit of normality for intraepithelial lymphocytes (IELs) per 100 enterocytes is set at 25, gastric biopsies (determination of H. Pylori by immunohistochemistry) and esophageal biopsies was recorded too.~Percentage of lymphocyte subpopulations are assessed by flow cytometry.
Study NCT01972685 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Cryobiopsy biopsy
Description: Cryobiopsy vs. Transbronchial vs. VATS biopsy
Study NCT04264637 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Azelastine hydrochloride (BAYR9258)
Description: Single dose, metered-spray solution, 2 sprays per nostril, 205.5 mcg/spray, intranasal administration.
Study NCT04264637 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Single dose of Azelastine hydrochloride-matched placebo, metered-spray solution, 2 sprays per nostril, intranasal administration.
Study NCT00514540 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Docetaxel
Description: 75 mg/m\^2 IV over 60 Minutes on Day 1 of 21 day cycle.
Study NCT00514540 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: AUC = 5 IV Over 30 Minutes On Day 1 of 21 day cycle.
Study NCT00514540 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Etoposide
Description: 120 mg/m\^2 daily for 3 days of 21 day cycle.
Study NCT00514540 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: 25 mg/m\^2 for 3 days of 21 day cycle.
Study NCT03134027 — intervention group
Intervention type: PROCEDURE
Intervention: Bone marrow biopsy
Description: Subjects will undergo a bone marrow biopsy to obtain aspirate for stem cell collection.
Study NCT03134027 — intervention group
Intervention type: PROCEDURE
Intervention: Tumor biopsy
Description: Subjects will undergo a tumor biopsy to obtain tissue for generation of a PDX.
Study NCT03233906 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Chia Seeds- Salvia Hispanica
Description: Chia seed added-10% of kcals and a no-chia control diet. 10% will be calculated using the following formula: Harris-Benedict equation multiplied by the activity factor of 1.2, 1.375, and 1.55 depending on each participant's activity level based on the information provided on the initial screening form.
Study NCT02529618 — intervention group
Intervention type: DEVICE
Intervention: integrated Display Enhanced Testing for Cognitive Impairment and mild traumatic brain injury (iDETECT)
Description: iDETECT offers an open platform for an evaluation of cognitive, balance, and oculomotor performance after mild traumatic brain injury (mTBI). It is a rugged, portable, neurocognitive assessment tool designed specifically for use in field and triage settings for the rapid evaluation of functional neurologic impairment after potential concussive injury.
Study NCT02529618 — intervention group
Intervention type: DEVICE
Intervention: Riddell High Impact Technology (HIT) System
Description: The Riddell HIT system incorporates six acceleration sensors into standard football helmets worn during practice and game play. A computerized sideline system captures information on linear and rotational acceleration, as well as magnitude, duration, and location of impact for each player
Study NCT01972685 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Transbronchial Biopsy
Study NCT01972685 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: VATS biopsy
Study NCT03930875 — intervention group
Intervention type: OTHER
Intervention: Aspirin Resistance testing
Description: Aspirin resistance will be measured using platelet aggregometry (VerifyNow assay)
Study NCT04395924 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Diagnosis of SARS-Cov2 by RT-PCR and : IgG, Ig M serologies in the amniotoc fluid, the blood cord and the placenta
Description: During labor and delivery~1. Sample of amniotic fluid~2. 2 samples of blood cord after the birth of the new born~3. 2 samples of placenta~These samples will be tested with A RT-PCR COVID-19 test and / or serology's A sample of blood cord and placenta will be frozen at -80 degree C and studied for PCR and viral proteome, cytokines , D-dimers and others inflammatory markers in the PRIMMO Laboratory (Prof. TOUMI and LESPESSAILLES) and after in the Centre of molecular biophysics of CNRS of Orleans (Prof. PICHON)
Study NCT03164031 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Close-fitting orthotic shorts
Description: The orthotic shorts will be custom-made by DM Orthotics, a UK based company that specialises in dynamic, elastomeric orthoses for healthcare and sport. They will provide both pairs of shorts for each participant, both constructed from a 275 g/m2 fabric, which is 51% Polyamide, 32% Dorlastan and 17% cotton. A company representative will assess each participant to decide the compression and fit of the shorts, such as whether support for the lower trunk is required. The shorts can be manufactured with a toileting hole, if preferred, allowing participants to toilet without removing the shorts. Shorts with a toileting hole are worn beneath usual underwear.
Study NCT03164031 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Looser fitting shorts
Description: Looser fitting shorts will be custom-made by DM Orthotics, a UK based company that specialises in dynamic, elastomeric orthoses for healthcare and sport. Shorts will be constructed from a 275 g/m2 fabric, which is 51% Polyamide, 32% Dorlastan and 17% cotton. A company representative will assess each participant to decide the fit of the shorts. The shorts can be manufactured with a toileting hole, if preferred, allowing participants to toilet without removing the shorts. Shorts with a toileting hole are worn beneath usual underwear.
Study NCT02987166 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: High-Dose Conformal Radiation Therapy
Description: 24 Gy in 3 fractions of 8Gy each for bone and/or soft tissue lesions~30 Gy in 5 fractions of 6 Gy each for prostate gland
Study NCT02987166 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: 200 mg
Study NCT02529618 — intervention group
Intervention type: DEVICE
Intervention: i1 Biometrics Vector Mouth Guard
Description: The i1 Biometrics Vector Mouth Guard is an impact intelligence system that contains a collection of impact sensing mouth guards, housing accelerometer and gyroscope technology that allows real-time collection and storage of biomechanical impact data. Sensors in the mouth guard communicate directly with a sideline assessment base station and allows for immediate assessment and evaluation of hit exposure.
Study NCT03529162 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Long head of Biceps Tenodesis
Description: Patients will be randomized into two different groups to compare biceps tenodesis techniques
Study NCT04778215 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: A progressive specific lumbar stabilization program
Description: The aim of these programs is to optimize the stabilization and control of segmental motion of the lumbar spine. It is based on the draw-in action, hereafter called the abdominal hollowing, presented by Richardson and Jull (1995). The training program consists of three levels. Level 1 introduces the abdominal hollowing exercise in the prone and four-point kneeling position. Level 2 is a progression of these exercises and the gymnasts are also instructed to perform the abdominal hollowing standing on a balance board with slightly flexed knees while slowly moving the arms. Level 3 takes the training into sports specificity and the abdominal hollowing are to be held during three different basic trampette jumps with emphasis on good trunk and body control during jumping and landing.
Study NCT04383041 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Completing questionnaires via ePRO app from their own mobile devices
Study NCT02212249 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: soluble Ve cadherin
Description: dosage of soluble VE cadherine in each arms
Study NCT02212249 — intervention group
Intervention type: BIOLOGICAL
Group type: SHAM_COMPARATOR
Intervention: soluble Ve cadherin
Description: dosage of soluble VE cadherine in each arms
Study NCT00918905 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Telemonitor
Description: Within 24 hours after the patient was discharged due to exacerbation in COPD the telemedicine equipment was installed at the patient's home. The patients were included for four weeks followed by a visit to the outpatient clinic with. The patient had the equipment for approximately one week and had at least one follow-up phone call. Televideo consultations could be made from 8 AM to 3 PM every day. The patient could call the telemedicine department in the same period.~During the televideo consultations the nurse made clinical observations (i.e. dyspnoea, anxiety), measured saturation and lung function and informed the patients how to prevent exacerbations. The telemedicine consultation was agreed on with the patient and the telemedicine nurse from day to day.
Study NCT03807258 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS)
Description: Evaluations by TMS
Study NCT03807258 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Transcranial magnetic stimulation (TMS)
Description: Evaluations by TMS
Study NCT02645435 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: hip replacement
Description: Total hip replacement
Study NCT05736003 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Laparoscopic cholecystectomy
Description: Removal of gallbladder laparoscopically
Study NCT05736003 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy
Description: Removal of gallbladder laparoscopically
Study NCT04380480 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: Concurrent chemoradiotherapy combined with enteral feeding by percutaneous endoscopic gastrostomy
Description: One or two weeks before CCRT, all patients will undergo a percutaneous endoscopic gastrostomy (PEG) to be administered enteral nutrition support(30-35 kcal/kg of energy, 1.2-1.5g/kg of protein and electrolyte supplementation each day). Nutritional supplements will be administered till 1 month after CCRT.~All patients will receive definitive radiotherapy combined with three cycles of S-1 (40mg/2, BID, po) on D1-14, D22-35, D43-56.
Study NCT01378156 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: JS7 plasmid DNA and MVA62B vaccine
Description: JS7 plasmid DNA (3 mg at weeks 1 and 9) and MVA62B vaccine (10(8) TCID(50) at weeks 17 and 25)
Study NCT03044730 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine
Description: Given PO
Study NCT03044730 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT03044730 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Given IV
Study NCT01785940 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Interscalene block
Description: Interscalene catheters will be placed under aseptic precautions in each patient by one of the investigators using combined peripheral nerve stimulation and ultrasound guidance to get twitch in the C5-C6 dermatomes and documented spread of injectate near C5-6 nerve roots. Twenty mL of 0.2% ropivacaine will be injected while documenting adequate drug spread under ultrasound. After 20 min of injection, the interscalene nerve block will be evaluated and considered successful with inability to abduct the shoulder and a decrease in perceived sensation to cold of the skin over the deltoid muscle.
Study NCT03389594 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Surgical guide
Description: Surgical Guide for this group will designed from 0.4mm voxel size
Study NCT01115114 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: TAU
Description: A medical assistant will provide feedback on and educational materials describing the meaning of lab values to individuals identified as needing follow-up for metabolic syndrome, and will provide educational materials regarding healthy eating and exercise. The psychiatrist will recommend that the individual contact a primary care physician to follow-up on out of range values, and alter behaviors (over eating, being sedentary) to help improve health.
Study NCT01115114 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: IMBED
Description: After identifying individuals through routine screening that need medical follow-up for metabolic syndrome, these individuals will be scheduled to see the on site primary care provider. Rapid scheduling (within 2 weeks) will be attempted. Patients will be seen by the primary care provider monthly or as needed as determined per patient. The primary care provider will prescribe medications for metabolic syndrome, discuss the patient with psychiatry staff and recommend follow-up appointments for physical problems based upon recommended guidelines and clinical judgment of necessity and urgency. Referral to a specialist will be made according to standard primary care practice guidelines. During the Metabolic Syndrome Clinic, if individuals bring up other medical conditions, they will be referred for treatment of these conditions to an outside primary care provider.